What is the recommended diagnostic workup and management for primary hyperparathyroidism in an adult?

Primary Hyperparathyroidism: Diagnostic Workup and Management

All patients with confirmed primary hyperparathyroidism (PHPT) should be offered parathyroidectomy as the only definitive cure, with surgery now recommended for both symptomatic and asymptomatic patients meeting guideline criteria. 1, 2, 3

Initial Diagnostic Workup

Biochemical Confirmation

When hypercalcemia is detected, proceed with the following essential laboratory tests 1, 4:

• Repeat serum calcium (corrected for albumin or measure ionized calcium directly) to confirm persistent elevation 4
• Intact PTH level - inappropriately normal or elevated PTH in the setting of hypercalcemia confirms PHPT 1
• Serum phosphate - typically low (≤0.70 mmol/L) in PHPT 5
• Serum creatinine/GFR - assess renal function 4
• 25-hydroxyvitamin D - identify and correct deficiency before surgery 4, 2
• 24-hour urine calcium and creatinine - rule out familial hypocalciuric hypercalcemia and assess stone risk 2

Diagnostic Ratios

The Ca × Cl/P ratio provides the highest specificity (89.2%) and positive predictive value (82.2%) for PHPT, while the Ca/P ratio offers the highest sensitivity (77.6%) for screening 5.

Target Organ Assessment

• Dual-energy X-ray absorptiometry (DXA) at lumbar spine, femoral neck, total femur, and distal forearm to assess bone mineral density 4, 2
• Renal ultrasound to detect nephrocalcinosis or kidney stones 4

Surgical Indications

Surgery is indicated for 2, 3:

• All symptomatic patients (kidney stones, osteoporosis, fractures, neurocognitive symptoms)
• Asymptomatic patients meeting any of these criteria:
  • Age <50 years
  • Serum calcium >1 mg/dL above upper limit of normal
  • Creatinine clearance <60 mL/min
  • T-score ≤-2.5 at any site or previous fragility fracture
  • 24-hour urine calcium >400 mg/day with increased stone risk

Surgery is more cost-effective than observation or pharmacologic therapy and should be considered for most asymptomatic patients. 2

Preoperative Imaging

Imaging Strategy

Preoperative imaging is essential only when surgery is planned and should guide the surgical approach 6, 2. The selection depends on local expertise, but dual-modality imaging improves accuracy 6.

First-Line Imaging Options 6, 7:

• Cervical ultrasonography - operator-dependent but widely available
• 99mTc-sestamibi (MIBI) scintigraphy - functional imaging
• 4D parathyroid CT (noncontrast, arterial, and venous phases) - highest accuracy, particularly for multiglandular disease 6, 7
• PET scans - emerging modality with high accuracy 7

Concordant results from multiple imaging modalities increase positive predictive value and surgical confidence. 6

Important Caveats:

• Nonlocalizing imaging does NOT exclude patients from surgery - bilateral exploration remains an option 2
• Never perform preoperative parathyroid biopsy 2
• Assess and manage clinically relevant thyroid disease during the same operation 2

Surgical Approach

Two Acceptable Surgical Options 2, 3:

1. Focused/Minimally Invasive Parathyroidectomy (MIP)

• Appropriate for single-gland disease with positive preoperative localization 2, 3
• Requires intraoperative PTH (IOPTH) monitoring via reliable protocol 2
• Success criteria: ≥50% PTH drop from baseline AND/OR levels <40 pg/mL 7
• Cure rates exceed 97% in experienced hands 3

2. Bilateral Neck Exploration

• Essential for known or suspected multiglandular disease 2
• MIP is NOT routinely recommended for multiglandular disease 2
• All four glands should be visualized 2

Surgical Expertise Matters

High-volume surgeons achieve significantly better outcomes with lower complication rates 2. The possibility of multiglandular disease should be routinely considered in all cases 2.

Intraoperative Considerations 2:

• Ex vivo aspiration of resected tissue may confirm parathyroid tissue
• Autotransplant devascularized normal parathyroid tissue to prevent permanent hypoparathyroidism
• Third-generation PTH assays reflect treatment success more rapidly than second-generation assays 6

Preoperative Optimization

Correct vitamin D deficiency before surgery to prevent postoperative hypocalcemia and hungry bone syndrome 4, 2. Postoperative calcium and vitamin D supplementation optimizes bone mineral density outcomes 4.

Postoperative Management

Immediate Postoperative Period 2:

• Monitor for hematoma - most critical complication
• Assess for hypocalcemia and symptoms (perioral numbness, paresthesias, Chvostek/Trousseau signs)
• Calcium supplementation as indicated based on symptoms and levels

Definition of Cure

Eucalcemia at >6 months postoperatively 2

Long-Term Outcomes 3:

• Bone mineral density improves over several years
• Quality of life improvements
• Enhanced long-term survival
• Specific anti-osteoporotic treatment with bisphosphonates post-surgery shows no additional advantage and cannot be recommended 4

Special Populations Requiring Expertise 2:

• Familial PHPT syndromes (MEN1, MEN2A, HPT-JT)
• Reoperative parathyroidectomy (lower cure rates, higher complications)
• Parathyroid carcinoma

Assay Considerations

For classic PHPT, the type of PTH assay (second vs. third generation) will not affect diagnosis or management because precise PTH concentration is less clinically relevant than the inappropriately elevated level relative to calcium 6. However, during parathyroid surgery, third-generation assays provide more rapid feedback on treatment success 6.